Through our strategic partnering initiative, continue pre-clinical development with us through our toxicology program. Our GLP-compliant program is SOP-driven – whether it be utilization of previously established protocols or the development of novel protocols. While the following highlights an overview of our capabilities, please feel free to contact us for further information on your study’s specific requirements.

  • Fulfills requirements for IND or CTA for rodent studies
  • Capabilities in pharmacokinetics (PK), tolerability, plasma elimination, metabolism, and efficacy
  • Acute, chronic, or subchronic toxicity
  • Single dose range finding or acute studies
  • Repeat dose studies
  • Routes of dosing include oral gavage, intraperitoneal, intravenous, intratumoral, intramuscular, and subcutaneous
  • Sources of sampling can include peripheral blood, tissues (including bone), tumors, urine, and stool
  • Includes comprehensive cbc/diff and chemical screen results
  • Complete pathology report